Climate Change Data

Environmental Metrics

ESG Focus Areas

• Environment
• Social
• Governance
• SDGs (Goal 3: Good Health and Well-being, Goal 8: Decent Work and Economic Growth)

Environmental Achievements

• Reduced energy consumption through remote work (office electricity usage)
• Reduced paper consumption through paperless initiatives

Social Achievements

• Development of diverse human resources and fostering of female leaders
• Promotion of health management
• Expansion of work style options

Governance Achievements

• Thorough compliance awareness
• Establishment of a robust monitoring system including external directors
• Fair and proactive information disclosure

Climate Goals & Targets

Environmental Challenges

• Not disclosed

Mitigation Strategies

• Not disclosed

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement

• Not disclosed

Climate-Related Risks & Opportunities

Physical Risks

• Not disclosed

Transition Risks

• Not disclosed

Opportunities

• Not disclosed

Reporting Standards

Frameworks Used: Null

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

• 3
• 8

Contribution to achieving universal health coverage (UHC) and decent work and economic growth.

Sustainable Products & Innovation

• Not disclosed

Awards & Recognition

• Not disclosed

Environmental Metrics

ESG Focus Areas

• Not disclosed

Environmental Achievements

• Not disclosed

Social Achievements

• Not disclosed

Governance Achievements

• Not disclosed

Climate Goals & Targets

Environmental Challenges

• Dependence on the medical and pharmaceutical industries; potential impact from healthcare market stagnation, downsizing, or inability to adapt to new market trends; global competition and industry restructuring in the pharmaceutical industry.
• Competition for physician acquisition and retention; potential for new entrants or similar services offered by other companies or pharmaceutical companies themselves, leading to increased competition and potential loss of competitive advantage.
• Handling of personal information; potential for data breaches and loss of physician trust, impacting services reliant on physician collaboration.
• Compliance with pharmaceutical and medical device laws; potential for violations of regulations related to medical and pharmaceutical information provision and advertising, leading to negative impacts on business performance.

Mitigation Strategies

• Diversification of clients through tailored service offerings and new product development; regular credit management to reduce client loss risk.
• Providing high-quality medical information to maintain physician satisfaction and attract new members; collaboration with physicians to build a more specialized site and increase physician membership to support pharmaceutical companies' sales and appropriate dissemination activities.
• Continuous education and awareness-raising among employees on personal information protection; adherence to personal information protection regulations; system security measures and access control to prevent information leaks.
• Information gathering and monitoring of relevant laws and regulations; measures to prevent violations; awareness-raising among specialists and employees regarding legal regulations.

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement

• Not disclosed

Climate-Related Risks & Opportunities

Physical Risks

• Not disclosed

Transition Risks

• Not disclosed

Opportunities

• Not disclosed

Reporting Standards

Frameworks Used: Null

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

• Not disclosed

Not disclosed

Sustainable Products & Innovation

• Not disclosed

Awards & Recognition

• Not disclosed